Target Details
| UniProt AC | O00329 |
|---|---|
| Gene Symbol | PIK3CD |
| Protein Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00454 (PI3_PI4_kinase) PF00792 (PI3K_C2) PF02192 (PI3K_p85B) PF00794 (PI3K_rbd) PF00613 (PI3Ka) |
Summary
- Multi-target molecules 3,772
- Clinical molecules 130
- Avg pChEMBL 7.48
KEGG Pathways (109)
- AGE-RAGE signaling pathway in diabetic complications
- AMPK signaling pathway
- Acute myeloid leukemia
- Aldosterone-regulated sodium reabsorption
- Alzheimer disease
- Amoebiasis
- Apoptosis
- Autophagy - animal
- Axon guidance
- B cell receptor signaling pathway
- Bacterial invasion of epithelial cells
- Breast cancer
- C-type lectin receptor signaling pathway
- Carbohydrate digestion and absorption
- Cellular senescence
- Central carbon metabolism in cancer
- Chagas disease
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Cholinergic synapse
- Chronic myeloid leukemia
- Colorectal cancer
- Coronavirus disease - COVID-19
- Diabetic cardiomyopathy
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- Epstein-Barr virus infection
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Fluid shear stress and atherosclerosis
- Focal adhesion
- FoxO signaling pathway
- Gastric cancer
- Glioma
- GnRH secretion
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Hormone signaling
- Human T-cell leukemia virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- IgSF CAM signaling
- Inflammatory mediator regulation of TRP channels
- Influenza A
- Inositol phosphate metabolism
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Leukocyte transendothelial migration
- Lipid and atherosclerosis
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- Measles
- Melanoma
- Metabolic pathways
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-alcoholic fatty liver disease
- Non-small cell lung cancer
- Osteoclast differentiation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Phosphatidylinositol signaling system
- Phospholipase D signaling pathway
- Platelet activation
- Platinum drug resistance
- Prion disease
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Regulation of lipolysis in adipocytes
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- Small cell lung cancer
- Sphingolipid signaling pathway
- Spinocerebellar ataxia
- T cell receptor signaling pathway
- TNF signaling pathway
- Thyroid hormone signaling pathway
- Toll-like receptor signaling pathway
- Type II diabetes mellitus
- VEGF signaling pathway
- Viral carcinogenesis
- Yersinia infection
- cAMP signaling pathway
- mTOR signaling pathway
Associated Diseases (3)
Active Molecules (3,772)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
SMMGDTUHUMCVSB
|
8.4 | IC50 | 2 | — | |
SSSURQNVDUYQTK
|
8.4 | IC50 | 6 | — | |
SUIQWWVKWMJPIF
|
8.4 | IC50 | 2 | — | |
SZIQCLLBUNFIMX
|
8.4 | IC50 | 3 | — | |
TTZDHGDYMSKHEK
|
8.4 | IC50 | 4 | — | |
UFKJHIYLVKAHJG
|
8.4 | IC50 | 2 | — | |
UMNVNHUOVNNHPM
|
8.4 | Ki | 4 | — | |
VDVLPUFQZDYPCJ
|
8.4 | IC50 | 3 | — | |
WLDAFMKORBHDLI
|
8.4 | IC50 | 3 | — | |
XBNSDTLFWKORGH
|
8.4 | Ki | 10 | — | |
XCNIZVNJZZCLLD
|
8.4 | IC50 | 2 | — | |
YATYYBFADSXZPJ
|
8.4 | IC50 | 2 | — | |
YCDFRPSSXVALLO
|
8.4 | IC50 | 2 | — | |
YSQFSEVNOOJNRC
|
8.4 | IC50 | 2 | — | |
YTBODSVQSOILIJ
|
8.4 | IC50 | 5 | — | |
YTFVFLULFAFNTO
|
8.4 | IC50 | 4 | — | |
ZCVHPIMJZCMSBM
|
8.4 | IC50 | 2 | — | |
ZHRILIZGJHYIID
|
8.4 | IC50 | 3 | — | |
ZMFSLMFEFNPUMJ
|
8.4 | IC50 | 5 | — | |
MODOHQQWQXQEQB
|
8.4 | IC50 | 4 | — | |
RGNZNWVPZKJPFW
|
8.4 | IC50 | 5 | — | |
VARVHYOTVXHELT
|
8.4 | IC50 | 5 | — | |
BUFXCNVHSXFTPL
|
8.4 | IC50 | 2 | — | |
RTARVPHTCQRSDW
|
8.4 | IC50 | 7 | Yes | |
ULKIEJUPHQMXQN
|
8.4 | IC50 | 5 | — | |
UPTYBPOYVNYQMT
|
8.4 | IC50 | 7 | — | |
IZHWRLKLKIUFPI
|
8.4 | IC50 | 4 | — | |
NIWBUWMZKOEJTN
|
8.4 | IC50 | 7 | — | |
RQZYVAOSDVOURA
|
8.4 | IC50 | 4 | — | |
UISOZEPWNXYPCK
|
8.4 | IC50 | 4 | — | |
YKIWXNATSYCOKT
|
8.4 | IC50 | 7 | Yes | |
FQCMZVNUJBMMGN
|
8.3 | Ki | 4 | — | |
GDUURIYHJNAYDO
|
8.3 | Ki | 4 | — | |
IUGGJYFHXIPYFI
|
8.3 | IC50 | 3 | — | |
MDMKWYWCJZMADI
|
8.3 | IC50 | 4 | — | |
MMPZSLSWQVQLJD
|
8.3 | IC50 | 7 | — | |
OUGUUEGNSCKSFE
|
8.3 | IC50 | 2 | — | |
VHJUNSAHYMIUCR
|
8.3 | IC50 | 4 | — | |
XCWUPAKUQSCUGQ
|
8.3 | IC50 | 4 | — | |
BUQPABJWAJTHTI
|
8.3 | IC50 | 2 | — | |
XIKOUZAURDUGPE
|
8.3 | IC50 | 4 | — | |
ANVFPKXUFOFFJV
|
8.3 | IC50 | 3 | — | |
CEANWFYTBJIQQX
|
8.3 | IC50 | 3 | — | |
NWEPOBGFMVZODN
|
8.3 | IC50 | 2 | — | |
PHDREWFIUFIHAL
|
8.3 | IC50 | 3 | — | |
QVYPYOVXCSHCCB
|
8.3 | IC50 | 2 | — | |
YCVKHDKWZXXMCB
|
8.3 | IC50 | 4 | — | |
GCPDASDQILCVJP
|
8.3 | IC50 | 2 | — | |
KXFLETDZYWFLRT
|
8.3 | IC50 | 2 | — | |
XUWANCNKCKJBND
|
8.3 | IC50 | 4 | — |